| 摘要 |
FIELD: medicine, oncology. ^ SUBSTANCE: the present innovation deals with inhibiting the growth of host's cerebral tumors. It deals with introducing therapeutically efficient quantity of integrin alphav antagonists being cyclo(Arg-Gly-Asp-D-Phe-[N-Me]-Val). The innovation enables to considerably inhibit cerebral oncogenesis in vivo, moreover, despite antiangiogenesis, due to induction of direct lethality of tumor cells. ^ EFFECT: higher efficiency of inhibition. ^ 9 dwg, 2 tbl |
